Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Protein Import into the Peroxisomes01:27

Protein Import into the Peroxisomes

Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Cohesins02:20

Cohesins

Cohesin protein complexes are a molecular glue that holds two sister chromatids together. They play an important role both in mitosis and meiosis. In mitosis, all cohesin complexes present on the chromosomes are removed before the start of the anaphase stage.
Cohesin complexes in Meiotic Division
Meiosis involves two distinct rounds of chromosomal segregation and cell divisions— Meiosis I followed by Meiosis II – producing four daughter cells. Meiosis I includes the separation of homologous...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low serum immunoglobulin levels in pediatric atopic dermatitis: association with disease severity and exploratory scores.

European journal of pediatrics·2026
Same author

An Under-Recognized Burden: Occupational Injuries in Adolescents and Young Adults Presenting to Emergency Care in Türkiye.

American journal of industrial medicine·2026
Same author

Distinguishing myocarditis from perimyocardial syndromes in children presenting to the emergency department: a biomarker-based approach.

BMC emergency medicine·2026
Same author

Clinical, immunological, treatment characteristics, and outcomes in 22 patients with major histocompatibility complex class II deficiency.

Frontiers in immunology·2026
Same author

Pneumococcal Serological Evaluation in Vaccinated Children Diagnosed with Transient Hypogammaglobulinemia of Infancy and Unclassified Hypogammaglobulinemia.

International archives of allergy and immunology·2026
Same author

A Rare Cause of Vesiculobullous Lesions in Childhood: 4 Cases of Cutaneous Mastocytosis.

Turkish archives of pediatrics·2026

Related Experiment Video

Updated: Jun 16, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Eponym. Kostmann disease.

Caner Aytekin1, Manuela Germeshausen, Nilden Tuygun

  • 1Dr. Sami Ulus Children's Health and Diseases Training and Research Center, 06080 Ankara, Turkey. caneraytekin@yahoo.com

European Journal of Pediatrics
|February 19, 2010
PubMed
Summary

Kostmann disease, a rare inherited neutropenia, was first described in 1956. Recent genetic research identified homozygous mutations in the HCLS1-associated X1 gene, clarifying its cause and inheritance pattern.

More Related Videos

Live Imaging and Analysis of Muscle Contractions in Drosophila Embryo
07:18

Live Imaging and Analysis of Muscle Contractions in Drosophila Embryo

Published on: July 9, 2019

Mitochondria-associated ER Membranes (MAMs) and Glycosphingolipid Enriched Microdomains (GEMs): Isolation from Mouse Brain
10:32

Mitochondria-associated ER Membranes (MAMs) and Glycosphingolipid Enriched Microdomains (GEMs): Isolation from Mouse Brain

Published on: March 4, 2013

Related Experiment Videos

Last Updated: Jun 16, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Live Imaging and Analysis of Muscle Contractions in Drosophila Embryo
07:18

Live Imaging and Analysis of Muscle Contractions in Drosophila Embryo

Published on: July 9, 2019

Mitochondria-associated ER Membranes (MAMs) and Glycosphingolipid Enriched Microdomains (GEMs): Isolation from Mouse Brain
10:32

Mitochondria-associated ER Membranes (MAMs) and Glycosphingolipid Enriched Microdomains (GEMs): Isolation from Mouse Brain

Published on: March 4, 2013

Area of Science:

  • Pediatrics
  • Genetics
  • Hematology

Background:

  • Rolf Kostmann first described infantile genetic agranulocytosis in 1956.
  • The underlying genetic cause of this inherited neutropenia remained elusive for decades.
  • Kostmann disease affects children with chronic neutropenia.

Discussion:

  • Homozygous mutations in the HCLS1-associated X1 gene were identified in patients with Kostmann disease.
  • This discovery links a specific gene mutation to the syndrome, justifying the eponym "Kostmann disease".
  • Understanding the genetic basis enables genotype-phenotype correlation analysis.

Key Insights:

  • Identification of homozygous mutations in HCLS1-associated X1 gene as the cause of Kostmann disease.
  • The eponym "Kostmann disease" is now scientifically supported for this specific genetic condition.
  • Genetic identification allows for detailed genotype-phenotype studies.

Outlook:

  • Recombinant human granulocyte colony-stimulating factor (G-CSF) has significantly improved patient prognosis and quality of life.
  • Hematopoietic stem cell transplantation is the primary treatment for G-CSF-refractory cases and leukemia transformation.
  • Further research into genotype-phenotype correlations may refine treatment strategies.